Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR

NCT04638985 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Vaccine

Interventions

BIOLOGICAL: sIPV+DTaP+MMR
BIOLOGICAL: sIPV
BIOLOGICAL: DTaP
BIOLOGICAL: MMR

Sponsor

China National Biotec Group Company Limited

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]